TY - JOUR
T1 - Repetition of intentional drug overdose
T2 - a population-based study
AU - The Canadian Drug Safety and Effectiveness Research Network (CDSERN)
AU - Finkelstein, Yaron
AU - Macdonald, Erin M.
AU - Hollands, Simon
AU - Sivilotti, Marco L.A.
AU - Hutson, Janine R.
AU - Mamdani, Muhammad M.
AU - Koren, Gideon
AU - Juurlink, David N.
N1 - Publisher Copyright:
© 2016 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2016/8/8
Y1 - 2016/8/8
N2 - Abstract: Context: Intentional overdose is a leading method of self-harm and suicide, and repeat attempts strongly predict eventual death by suicide. Objectives: To determine the risk of recurrence after a first intentional overdose. Secondary objectives included characterization of the temporal course and potential predictors of repeat overdose, a strong risk factor for death from suicide. Methods: Design: Population-based cohort study. Setting: Ontario, Canada, from 1 April 2002 to 31 March 2013. Participants: All Ontario residents presenting to an emergency department after a first intentional overdose. Main outcome measures: The incidence and timing of recurrent overdose. Results: We followed 81,675 patients discharged from hospital after a first intentional overdose. Overall, 13,903 (17.0%) returned with a repeat overdose after a median interval of 288 (inter-quartile range: 62 to 834) days. Of these, 4493 (5.5%) had multiple repeat episodes. Factors associated with repeat self-poisoning included psychiatric care in the preceding year (adjusted hazard ratio [aHR] 1.55; 95% confidence interval [CI] 1.50 to 1.61), alcohol dependence (aHR 1.41; 95% CI 1.35 to 1.46) and documented depression (aHR 1.39; 95% CI 1.34 to 1.44). Female sex, rural residence, lower socioeconomic status, ingestion of psychoactive drugs and younger age were also weakly associated with repeat overdose. Discussion: Hospital presentation for repetition of intentional overdose is common, with recurrent episodes often far removed from the first. While several factors predict overdose repetition, none is particularly strong. Conclusion: Secondary prevention initiatives should be implemented for all individuals who present to the emergency department and survive intentional overdose.
AB - Abstract: Context: Intentional overdose is a leading method of self-harm and suicide, and repeat attempts strongly predict eventual death by suicide. Objectives: To determine the risk of recurrence after a first intentional overdose. Secondary objectives included characterization of the temporal course and potential predictors of repeat overdose, a strong risk factor for death from suicide. Methods: Design: Population-based cohort study. Setting: Ontario, Canada, from 1 April 2002 to 31 March 2013. Participants: All Ontario residents presenting to an emergency department after a first intentional overdose. Main outcome measures: The incidence and timing of recurrent overdose. Results: We followed 81,675 patients discharged from hospital after a first intentional overdose. Overall, 13,903 (17.0%) returned with a repeat overdose after a median interval of 288 (inter-quartile range: 62 to 834) days. Of these, 4493 (5.5%) had multiple repeat episodes. Factors associated with repeat self-poisoning included psychiatric care in the preceding year (adjusted hazard ratio [aHR] 1.55; 95% confidence interval [CI] 1.50 to 1.61), alcohol dependence (aHR 1.41; 95% CI 1.35 to 1.46) and documented depression (aHR 1.39; 95% CI 1.34 to 1.44). Female sex, rural residence, lower socioeconomic status, ingestion of psychoactive drugs and younger age were also weakly associated with repeat overdose. Discussion: Hospital presentation for repetition of intentional overdose is common, with recurrent episodes often far removed from the first. While several factors predict overdose repetition, none is particularly strong. Conclusion: Secondary prevention initiatives should be implemented for all individuals who present to the emergency department and survive intentional overdose.
KW - Recidivism
KW - self-poisoning
KW - suicide
UR - http://www.scopus.com/inward/record.url?scp=84966693493&partnerID=8YFLogxK
U2 - 10.1080/15563650.2016.1177187
DO - 10.1080/15563650.2016.1177187
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27172384
AN - SCOPUS:84966693493
SN - 1556-3650
VL - 54
SP - 585
EP - 589
JO - Clinical Toxicology
JF - Clinical Toxicology
IS - 7
ER -